保密 | 投資責任聲明 | 聯繫我們
Excorp Medical's Bioartificial Liver System comprises a reusable instrument, disposable tubing set and the proprietary, disposable bioartificail reactor.Once approved by regulatory agencies, Excorp Medical expects this breakthrough Bioartificial Liver System technology to be both live-saving and cost effective.Certain drugs or machines are available to substitute temporarily or long-term for many organs in the body…  no comparable substitute has been developed for the liver.The liver is the largest organ in the body and performs a variety of tasks impacting all body systems… as a result liver disease has widespread effects on virtually all other organs.Excorp Medical is currently the only company approved to conduct bioartificial liver human trials within the U.S.Currently patients must receive a liver transplant or endure prolonged hospitalization at great expense to have a chance at survival.Excorp Medical Bioartificial Liver System treatments serve as a bridge to liver regeneration and transplantExcorp Medical has developed a Bioartificial Liver System for the metabolic support of patients with compromised liver function.
Chinese Simplified
简体中文
Chinese Traditional
繁體中文
Arabic
關聯單位
若需更多資訊，請點擊下方按鈕

匹茲堡大學

臨床試驗中心
香港大學醫學院
The Chinese University of Hong Kong
香港中文大學
Hong Kong Science & Technology Parks
香港科技園
Shinva
新華醫療器械股份有限公司
Hani Securities (H.K.) Ltd.
恒利證券（香港）有限公司
Hep C Connection
乙肝線上
(www.hepc-connection.org)

關聯單位

匹茲堡大學
University of Pittsburgh

匹茲堡大學
湯瑪斯 E 斯達茲器官移植研究所

在新視窗中打開該網址

University of Pittsburgh

臨床試驗中心
香港大學醫學院

香港大學臨床試驗中心 （CTC）
首屈一指的臨床試驗研究院

在新視窗中打開該網址

The Chinese University of Hong Kong

香港中文大學

香港中文大學
揉合古今 銜接中西

在新視窗中打開該網址

Hong Kong Science & Technology Parks

香港科技園

在新視窗中打開該網址

Shinva

新華醫療器械股份有限公司

在新視窗中打開該網址

The Hani Securities (H.K.) Ltd.

恒利證券（香港）有限公司

金融分析精確 時刻緊貼香港股市脈搏

在新視窗中打開該網址

Hep C Connection

乙肝線上 (www.hepc-connection.org)

肝炎知多少

在新視窗中打開該網址

新聞
關聯單位
出版文章
臨床研究
招聘
致投資者
©2014 Excorp Medical, Inc.